Ko Kudo

599 total citations
25 papers, 227 citations indexed

About

Ko Kudo is a scholar working on Physiology, Oncology and Molecular Biology. According to data from OpenAlex, Ko Kudo has authored 25 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Ko Kudo's work include Histiocytic Disorders and Treatments (10 papers), Acute Myeloid Leukemia Research (5 papers) and Parvovirus B19 Infection Studies (4 papers). Ko Kudo is often cited by papers focused on Histiocytic Disorders and Treatments (10 papers), Acute Myeloid Leukemia Research (5 papers) and Parvovirus B19 Infection Studies (4 papers). Ko Kudo collaborates with scholars based in Japan, United States and Sweden. Ko Kudo's co-authors include Dario Campana, Chihaya Imai, Andrew M. Davidoff, Koji Kono, Takahiro Kamiya, Wee Joo Chng, Yoshihisa Fukushima, Takafumi Tomiyasu, Etsuro Ito and Yoshihiro Jinno and has published in prestigious journals such as Cancer Research, Scientific Reports and Human Pathology.

In The Last Decade

Ko Kudo

20 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ko Kudo Japan 6 160 83 76 57 53 25 227
Felix Korell Germany 10 258 1.6× 76 0.9× 78 1.0× 60 1.1× 78 1.5× 22 329
Maria A. V. Marzolini United Kingdom 9 229 1.4× 35 0.4× 68 0.9× 61 1.1× 59 1.1× 21 310
Ruimin Hong China 9 283 1.8× 60 0.7× 127 1.7× 72 1.3× 75 1.4× 29 355
Xiaoqian Liang China 6 243 1.5× 54 0.7× 117 1.5× 68 1.2× 98 1.8× 8 334
Victoria Shi United States 4 279 1.7× 123 1.5× 91 1.2× 69 1.2× 88 1.7× 17 336
Claudia Diamonte United States 10 322 2.0× 84 1.0× 73 1.0× 108 1.9× 79 1.5× 18 353
Vincent Allain France 9 231 1.4× 52 0.6× 179 2.4× 99 1.7× 81 1.5× 22 388
Aleksei Titov Russia 7 214 1.3× 61 0.7× 122 1.6× 70 1.2× 147 2.8× 13 368
Viktoria Blumenberg Germany 10 304 1.9× 57 0.7× 61 0.8× 72 1.3× 51 1.0× 32 361
Jan Koedam Netherlands 6 173 1.1× 53 0.6× 83 1.1× 54 0.9× 46 0.9× 9 222

Countries citing papers authored by Ko Kudo

Since Specialization
Citations

This map shows the geographic impact of Ko Kudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Kudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Kudo more than expected).

Fields of papers citing papers by Ko Kudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko Kudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Kudo. The network helps show where Ko Kudo may publish in the future.

Co-authorship network of co-authors of Ko Kudo

This figure shows the co-authorship network connecting the top 25 collaborators of Ko Kudo. A scholar is included among the top collaborators of Ko Kudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Kudo. Ko Kudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Umeda, Katsutsugu, Atsushi Yokoyama, Takeshi Yoshida, et al.. (2024). Juvenile xanthogranuloma manifesting with LCH‐associated neurodegenerative disease‐like radiological findings. Pediatric Blood & Cancer. 71(7). e31043–e31043.
2.
Tanaka, Tatsuhiko, Ko Kudo, Rika Kanezaki, et al.. (2024). Antileukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome. Experimental Hematology. 132. 104179–104179. 2 indexed citations
3.
Watanabe, Ryota, Takao Sasaki, Shohei Kinoshita, et al.. (2023). Spontaneous remission of skull Langerhans cell histiocytosis that had developed by repeated head injury: illustrative case. Journal of Neurosurgery Case Lessons. 6(8). 1 indexed citations
4.
Shimizu, Soichiro, Kenichi Sakamoto, Ko Kudo, Akira Morimoto, & Yoko Shioda. (2023). Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis. International Journal of Hematology. 118(1). 119–124. 1 indexed citations
5.
6.
Fukuoka, Kohei, Yoshiyuki Ihara, Ko Kudo, et al.. (2022). Optimal timing of liver transplantation for liver cirrhosis caused by sclerosing cholangitis in a patient with Langerhans cell histiocytosis: a case report. International Journal of Hematology. 117(5). 759–764.
7.
Inoue, Kento, Yasuo Horikoshi, Takashi Ishihara, et al.. (2022). Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan. Journal of Clinical Immunology. 43(3). 585–594. 2 indexed citations
8.
Kanezaki, Rika, Tsutomu Toki, Kiminori Terui, et al.. (2022). Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome–related myeloid disorders. Scientific Reports. 12(1). 20587–20587.
9.
Morimoto, Akira, et al.. (2022). [Elucidated pathogenesis and therapeutic prospects in Langerhans cell histiocytosis].. PubMed. 63(5). 373–382.
10.
Sakamoto, Kenichi, Yoko Shioda, Takehiko Doi, et al.. (2021). Salvage therapy with 2-chlorodeoxyadenosine for refractory and relapsed pediatric Langerhans cell histiocytosis: an updated nationwide survey in Japan. International Journal of Hematology. 113(3). 461–463. 3 indexed citations
11.
Kudo, Ko, Tomohiko Sato, Yuka Takahashi, et al.. (2021). Association of Multiple Gene Polymorphisms Including Homozygous NUDT15 R139C With Thiopurine Intolerance During the Treatment of Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 43(8). e1173–e1176. 1 indexed citations
12.
13.
Terui, Kiminori, Tsutomu Toki, Rika Kanezaki, et al.. (2020). Clinical, cytogenetic, and molecular analyses of 17 neonates with transient abnormal myelopoiesis and nonconstitutional trisomy 21. Pediatric Blood & Cancer. 67(4). e28188–e28188. 5 indexed citations
14.
Terui, Kiminori, Tsutomu Toki, Takashi Taga, et al.. (2019). Highly sensitive detection of GATA1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing. Genes Chromosomes and Cancer. 59(3). 160–167. 7 indexed citations
15.
Kuwahara, K., Ko Kudo, Akiko Yashima‐Abo, et al.. (2018). Classic Hodgkin lymphoma with osseous involvement mimicking Langerhans cell histiocytosis in a child. Human Pathology. 77. 147–151. 1 indexed citations
16.
Kudo, Ko, Hiroo Ueno, Tomohiko Sato, et al.. (2018). Two siblings with familial neuroblastoma with distinct clinical phenotypes harboring an ALK germline mutation. Genes Chromosomes and Cancer. 57(12). 665–669. 2 indexed citations
17.
Egami, Shohei, et al.. (2015). Blastic Plasmacytoid Dendritic Cell Neoplasm in a 7-year-old Girl with a Solitary Skin Lesion Mimicking Traumatic Purpura. Acta Dermato Venereologica. 95(2). 231–232. 6 indexed citations
18.
Kudo, Ko, Chihaya Imai, Takahiro Kamiya, et al.. (2013). T Lymphocytes Expressing a CD16 Signaling Receptor Exert Antibody-Dependent Cancer Cell Killing. Cancer Research. 74(1). 93–103. 159 indexed citations
19.
Terui, Kiminori, et al.. (2010). Guillain-Barré Syndrome Mimicking Acute Methotrexate-associated Encephalopathy in an Adolescent Patient With Lymphoblastic Lymphoma. Journal of Pediatric Hematology/Oncology. 32(8). 615–616. 4 indexed citations
20.
Naoe, T, Ko Kudo, Hitoshi Yoshida, Keizo Horibe, & R Ohno. (1997). Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia.. PubMed. 11 Suppl 3. 287–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felix Korell Breakdown of academic impact, for papers by Maria A. V. Marzolini Breakdown of academic impact, for papers by Ruimin Hong Breakdown of academic impact, for papers by Xiaoqian Liang Breakdown of academic impact, for papers by Victoria Shi Breakdown of academic impact, for papers by Claudia Diamonte Breakdown of academic impact, for papers by Vincent Allain Breakdown of academic impact, for papers by Aleksei Titov Breakdown of academic impact, for papers by Viktoria Blumenberg Breakdown of academic impact, for papers by Jan Koedam
Rankless by CCL
2026